Background illustration for clinical trials search

Paid Clinical Trials Maryland

Discover 2,427 paid clinical trials in Maryland. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1
Active & Responsive

Pivotal Study of N-acetyl-L-leucine for CACNA1A

for
CACNA1A, Spinocerebellar Ataxia Type 6, Episodic Ataxia Type 2,
Location: Boston MA, Baltimore MD, Houston TX
Sponsor: IntraBio Inc

Sex: All

Age: 4+

Code: NCT07221292

Phase3, Recruiting
Active & Responsive

A Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid Syndrome

for
Phelan-McDermid Syndrome
Location: Brookline MA, Lexington MA, New York NY,
Sponsor: Neuren Pharmaceuticals Limited

Sex: All

Age: 3 - 12

Code: NCT07281079

Phase3, Recruiting
Active & Responsive

QST Study: Predicting Treatment Response in Chronic Pancreatitis Using Quantitative Sensory Testing

for
Chronic Pancreatitis, Chronic Pain
Location: Baltimore MD, Pittsburgh PA
Sponsor: Anna Evans Phillips

Sex: All

Age: 18+

Code: NCT03434392

Recruiting
Active & Responsive

Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV

for
Human Papilloma Virus, Anal Dysplasia, HIV
Location: Baltimore MD
Sponsor: University of Maryland, Baltimore

Sex: Male

Age: 18 - 70

Code: NCT06624839

Phase2, Recruiting
Active & Responsive

DReAMzz- Dronabinol and Acetazolamide Medication for Sleep Apnea (ZZ). Dose Confirmation Crossover Study for IHL-42X in Subjects With Obstructive Sleep Apnea.

for
Obstructive Sleep Apnea (OSA)
Location: Rockville MD, West Palm Beach FL, Orlando FL,
Sponsor: Incannex Healthcare Ltd

Sex: All

Age: 18 - 65

Code: NCT07635563

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Measuring the Effects of Netarsudil, Latanoprost, and Combination Therapy on Episcleral and Retinal Blood Flow in Ocular Hypertension and Glaucoma Suspects

for
Ocular Hypertension, Suspect Glaucoma
Location: Baltimore MD, Columbia MD, Silver Spring MD
Sponsor: University of Maryland, Baltimore

Sex: All

Age: 18+

Code: NCT04401982

Recruiting
Active & Responsive

Assessing Administration of pBI-11 Via Electroporation for the Treatment of Patients With HPV16/18+

for
HPV Infection
Location: Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: Female

Age: 18+

Code: NCT06210854

Phase2, Recruiting
Active & Responsive

Ruxolitinib for Immune Effector Cell Associated Hemophagocytic Lymphohistiocytosis-like Syndrome (RISE)

for
Immune Effector Associated Hemophagocytic Lymphohistiocytosis-like Syndrome (IEC-HS),
Location: Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All

Age: 18 - 70+

Code: NCT07424222

Phase1, Recruiting
Active & Responsive

Toxin Exposure and Immune Dysregulation in Non-Hodgkin Lymphoma

for
Non-Hodgkin Lymphoma, Lymphoma Non-Hodgkin, B-cell Lymphoma,
Location: Bethesda MD
Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine

Sex: All

Age: 4+

Code: NCT07652580

Recruiting
Active & Responsive

Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors

for
Sub-study 1 Cervical Cancer (Volrustomig Monotherapy),
Location: Stony Brook NY, New York NY, Montreal, Baltimore MD,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06535607

Phase2, Recruiting
Active & Responsive

A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)

for
Primary Myelofibrosis (PMF),
Location: New Haven CT, Albany NY, Berkeley Heights NJ,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07357727

Phase3, Recruiting
Active & Responsive

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)

for
Macular Degeneration, Age-Related Macular Degeneration,
Location: Portland ME, Waterford CT, Manchester CT,
Sponsor: EyeBiotech Ltd.

Sex: All

Age: 50+

Code: NCT07496567

Phase2, Phase3, Recruiting
Active & Responsive

Bladder EpiCheck Product Development Study

for
Suspicion of Bladder Cancer, NMIBC Surveillance
Location: Towson MD, San Diego CA
Sponsor: Nucleix Ltd.

Sex: All

Age: 22+

Code: NCT07514143

Recruiting
Active & Responsive

Vibrotactile Balance Belt Effect on Improving Gait

for
Vestibular Hypofunction, Ataxia - Other, Gait Impairment
Location: Baltimore MD
Sponsor: Johns Hopkins University

Sex: All

Age: 18 - 70+

Code: NCT07253532

Recruiting
Active & Responsive

Impact of Physical Functioning on Patient-Reported Outcomes in ALS Patients at TidalHealth

for
Amyotrophic Lateral Sclerosis, Motor Neuron Disease
Location: Salisbury MD
Sponsor: TidalHealth, Inc.

Sex: All

Age: 18+

Code: NCT07491484

Recruiting
Active & Responsive

Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cemiplimab (REGN2810), in Treating Refractory Microsatellite Stable Colorectal Cancer

for
Metastatic Colorectal Adenocarcinoma,
Location: Baltimore MD, Washington D.C. DC, Atlanta GA, Aurora CO
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07147231

Phase1, Phase2, Recruiting
Active & Responsive

Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT)

for
Tetraplegia/Tetraparesis, Amyotrophic Lateral Sclerosis (ALS),
Location: Baltimore MD
Sponsor: Johns Hopkins University

Sex: All

Age: 18 - 70+

Code: NCT07521930

Recruiting
Active & Responsive

Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease

for
Primary Sjogren's Disease
Location: Boston MA, Willow Grove PA, Chesapeake VA, Rockville MD,
Sponsor: Vor Biopharma

Sex: All

Age: 18 - 70+

Code: NCT07404865

Phase3, Recruiting
Active & Responsive

Tirzepatide in MetALD

for
Metabolic Alcohol-associated Liver Disease,
Location: Bethesda MD
Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Sex: All

Age: 21 - 70+

Code: NCT07046819

Phase2, Recruiting
Active & Responsive

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

for
Glioblastoma (GBM), Newly Diagnosed Glioblastoma, GBM,
Location: Boston MA, New Haven CT, Lake Success NY, The Bronx NY,
Sponsor: Black Diamond Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07326566

Phase2, Recruiting

Popular cities in Maryland

AnnapolisBethesdaBaltimoreRockville